Abbott Laboratories Forecast, price target & analysts
Abbott Laboratories Target price 2025 - Analyst rating & recommendation
Abbott Laboratories Classifications & Recommendation:
Abbott Laboratories Price Target
| Target Price | $146.43 |
| Price | $134.38 |
| Potential |
8.97%
register free of charge
|
| Number of Estimates | 27 |
|
27 Analysts have issued a price target Abbott Laboratories 2026 .
The average Abbott Laboratories target price is $146.43.
This is
8.97%
register free of charge
$166.95
24.24%
register free of charge
$121.32
9.72%
register free of charge
|
|
| A rating was issued by 32 analysts: 21 Analysts recommend Abbott Laboratories to buy, 11 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Abbott Laboratories stock has an average upside potential 2026 of
8.97%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 41.95 | 45.12 |
| 4.59% | 7.56% | |
| EBITDA Margin | 21.15% | 26.95% |
| 2.37% | 27.44% | |
| Net Margin | 31.95% | 20.10% |
| 123.90% | 37.08% |
30 Analysts have issued a sales forecast Abbott Laboratories 2025 . The average Abbott Laboratories sales estimate is
This results in the following potential growth metrics:
21 Analysts have issued an Abbott Laboratories EBITDA forecast 2025. The average Abbott Laboratories EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
30 Abbott Laboratories Analysts have issued a net profit forecast 2025. The average Abbott Laboratories net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 7.67 | 5.21 |
| 134.56% | 32.07% | |
| P/E | 25.78 | |
| EV/Sales | 5.32 |
30 Analysts have issued a Abbott Laboratories forecast for earnings per share. The average Abbott Laboratories EPS is
This results in the following potential growth metrics and future valuations:
Abbott Laboratories...
Current Abbott Laboratories Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Locked
➜
Locked
|
Locked | Apr 17 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Apr 17 2025 |
| Raymond James |
Locked
➜
Locked
|
Locked | Apr 17 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Apr 17 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Apr 17 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Apr 17 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Apr 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Apr 17 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Apr 17 2025 |
|
Locked
Raymond James:
Locked
➜
Locked
|
Apr 17 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Apr 17 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Apr 17 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Apr 17 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Apr 17 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
